Related Experiment Video
Updated: Aug 5, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
Metabolically Healthy Obesity, Its Resolution, and the Risk of Incident Hepatic Steatosis in Chinese Children:
Jiaxiang Wang1, Lili Yang1, Zhuo Gong2
1State Key Laboratory of Reproductive Medicine and Offspring Health, Department of Epidemiology/Department of Maternal, Child and Adolescent Health, School of Public Health, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Introduction:
The prospective association between metabolically healthy obesity (MHO) and incident hepatic steatosis in children remains unclear. This study aimed to investigate the prospective associations of baseline MHO and its dynamic changes with incident hepatic steatosis in Chinese children.
Methods:
We included 2,192 children aged 6-11 years, drawn from 2 prospective cohorts with approximately 4 years of follow-up. Weight status was classified using body mass index according to the World Health Organization growth charts, and metabolic status was defined based on International Diabetes Federation criteria. Changes in metabolic health phenotypes from baseline to follow-up were also assessed. Incident hepatic steatosis was defined by ultrasonographic steatosis and/or elevated alanine aminotransferase.
Results:
MHO at baseline was associated with a significantly higher risk of incident hepatic steatosis (odds ratio [OR] = 7.23, 95% CI: 4.73-11.07) compared with metabolically healthy normal weight (MHN). Relative to children who remained MHN at both time points, those with persistent MHO had a markedly higher risk of hepatic steatosis (OR = 9.40, 95% CI: 5.47-16.15). By contrast, transition from MHO to MHN was not significantly associated with incident hepatic steatosis (OR = 1.89, 95% CI: 0.24-15.10).
Discussion:
Among Chinese children, baseline or persistent MHO was associated with an increased risk of incident hepatic steatosis. Importantly, conversion from MHO to MHN was not significantly associated with this risk, suggesting that the resolution of MHO may attenuate future hepatic risk. These findings extend the existing evidence on childhood obesity by highlighting the dynamic nature of MHO and support early weight management and liver health monitoring in children with obesity, irrespective of their baseline metabolic status.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Cholesterol: Significance and Regulation
Considering cholesterol and...
Type II Diabetes I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

